HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nicolas van Baren Selected Research

HLA-A1 Antigen (HLA A1 Antigen)

3/2008Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells.
2/2006Analysis of a rare melanoma patient with a spontaneous CTL response to a MAGE-A3 peptide presented by HLA-A1.
12/2005Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells.
1/2005Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.
10/2004Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.
11/2003Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Nicolas van Baren Research Topics

Disease

15Neoplasms (Cancer)
09/2015 - 10/2002
14Melanoma (Melanoma, Malignant)
08/2014 - 11/2003
4Neoplasm Metastasis (Metastasis)
08/2014 - 05/2004
1Carcinoma (Carcinomatosis)
08/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2004
1Leukemia
01/2004

Drug/Important Bio-Agent (IBA)

8AntigensIBA
09/2015 - 10/2002
6HLA-A1 Antigen (HLA A1 Antigen)IBA
03/2008 - 11/2003
6PeptidesIBA
03/2008 - 10/2002
4Messenger RNA (mRNA)IBA
08/2014 - 01/2007
3Neoplasm Antigens (Tumor Antigens)IBA
08/2011 - 10/2002
2EnzymesIBA
09/2015 - 01/2015
2VaccinesIBA
08/2011 - 05/2004
2HLA-A2 Antigen (HLA A2 Antigen)IBA
02/2011 - 05/2004
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
11/2005 - 05/2004
1Tryptophan (L-Tryptophan)FDA Link
09/2015
1Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA
09/2015
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2015
1DNA (Deoxyribonucleic Acid)IBA
08/2014
1MicroRNAs (MicroRNA)IBA
08/2014
1Melanoma-Specific AntigensIBA
02/2011
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2011
1Microphthalmia-Associated Transcription FactorIBA
10/2010
1Differentiation AntigensIBA
10/2010
1InterleukinsIBA
10/2010
1Monophenol Monooxygenase (Tyrosinase)IBA
10/2010
1Interleukin-1 (Interleukin 1)IBA
10/2010
1CytokinesIBA
10/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2010
1HLA-DP4IBA
03/2008
1Staphylococcal Protein A (A, Protein)IBA
01/2007
1Proteins (Proteins, Gene)IBA
11/2005
1MART-1 AntigenIBA
05/2004
1QS 21 (QS21)IBA
05/2004
1Complementary DNA (cDNA)IBA
01/2004

Therapy/Procedure

3Immunotherapy
03/2014 - 01/2003
1Transplants (Transplant)
03/2014